Experience of using a probiotic strain of Enterococcus in long-term nutritional support for premature children

Objective. To evaluate the experience of using a probiotic strain of enterococcus in long-term nutritional support of premature infants.

Characteristics of children and research methods. The children were selected in 2014–2015. The study included 11 premature babies of the first year of life, treated with antibiotics for a long time. Inclusion criteria: prematurity of any severity, signed informed consent from parents to conduct an outpatient rehabilitation program for children, including long-term nutritional support with a probiotic strain of enterococcus. Exclusion criteria: gross congenital malformations; hereditary metabolic diseases, severe forms of organic pathology of the central nervous system. Exclusion criteria: severe forms of somatic and infectious pathology, use of other probiotics. The probiotic strain of enterococcus – E. faecium L3 (No. RU. 77.99.26.009.Е.002272.02.11) in the liquid form (biomass grown on a dairy-free basis) with a titer of at least 10⁸ CFU/ml was orally administered to children 1 ml 2 times a day while eating. The authors evaluated safety and clinical efficacy of long-term use of the probiotic strain of enterococcus.

Results. The authors noted the effectiveness of long-term use of a probiotic strain of enterococcus as nutritional support for premature infants for adequate psychomotor and physical development. They revealed the disappearance of the manifestations of atopic dermatitis while taking a probiotic strain of enterococcus. In the course of the study, the safety of long-term intake of a probiotic strain of enterococcus was established as an integral part of the rehabilitation program for premature babies, who completed their nursing in a hospital.

Conclusion. The continuation of studies to assess the clinical efficacy of long-term intake of probiotics in children of the first year of life who were born prematurely and received antibiotics for a long time can be considered very promising.

1. Lo Skiavo L.A., Gonchar N.V., Suvorov A.N., Shabalov N.P., Fedorova M.S. Probiotics in the nutrition of preterm infants (literature review). Voprosy prakticheskoi pediatrii 2014; 9(6): 32–36. (in Russ.)

2. Suvorov AN. Microbiota of children. Priroda 2011; 11: 14–21. (in Russ.)

3. Gonchar N.V., Alekhina L.A., Suvorov A.N. Probiotic enterococcal strains as agents for therapy and prevention of bowel disease in children (literature review). Eksperimental’naya i klinicheskaya gastroenterologiya 2013; 1: 74–78 (in Russ.)

4. Mego M., Ebringer L., Drgona L., Mardiak J., Trupl J., Greksak R. et al. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma 2005; 52(2): 159–164. DOI: 10.1007/s00520-005-0891-7

5. Fujimori S., Tatsuguchi A., Gudis K., Kishida T., Mitsui K., Ehara A. et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease. J Gastroenterol Hepatol 2007; 22(8): 1199–1204. DOI: 10.1111/j.1440-1746.2006.04535.x

6. Saxelin M. LGG-Summation: Lactobacillus GG and its health effects. Helsinki: Valio Lt., 2002; 60

7. Gonchar N.V., Suvorov A.N., Fedorova M.S. The problem of probiotic dose selection in physician practice. Eksperimental’naya i klinicheskaya gastroenterologiya 2014; 1: 46–52. (in Russ.)

8. Valiulina A.Ya., Ahmadeeva E.N., Kryvkina N.N. Problems and prospects for successful nursing and rehabilitation of children with low and extremely low body weight. Vestnik sovremennoi klinicheskoi meditsiny 2013; 6(1): 34–41. (in Russ.)

9. Gonchar N.V., Lo Skiavo L.A., Alekhina G.G. Nutritive properties of probiotic enterococcus strain when used in preterm newborns. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii 2015; XXV(5). Prilozhenie №46: 94. (in Russ.)

10. Gonchar N.V., Suvorov A.N., Maryshev V.P., Sorokina T.M., Churkova T.V., Harit S.M. Probiotics, nutritive status and resistance to respiratory infections in children of the first year of life. Eksperimental’naya i klinicheskaya gastroenterologiya 2015; 113(1): 48–54. (in Russ.)

11. Bel’mer S.V., Razumovskiy A.Yu., Khavkin A.I., Alkhasov A.B., Bekhtereva M.K., Volynets G.V. et al. Bowel disease in children. Moscow: Medpraktika-M, 2018; Vol. 2: 496. (in Russ.)

12. Bel’mer S.V., Khavkin A.I., Ales hina Ye.O., Aleshkin A.V., Bekhtereva M.K., Bogdanova N.M. et al. Intestinal microbiota in children: the norm, violations, correction. Moscow: Medpraktika-M, 2019; 472. (in Russ.)